SHARE
 
Peiman Hematti, MD close
6SrNJEnsIXs
Peiman Hematti, MD
 

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Peiman Hematti, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Peiman Hematti joined the Section of Hematology/Bone Marrow Transplantation at the University of Wisconsin-Madison in July 2004 as an Assistant Professor in the Department of Medicine. Dr. Hematti has completed a combined Internal Medicine/Pediatrics residency at the Cleveland Clinic Foundation and then Hematology fellowship at the National Heart, Lung and Blood Institute at the National Institutes of Health. His clinical interests are in inpatient care of hematopoietic stem cell transplant patients. He is the director of the clinical hematopoietic cell processing laboratory, and in that capacity oversees all the peripheral blood stem cell collections from the patients and processing of their products.

Specialties

Clinics

UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Medicine
Department of Pediatrics

Professional Certifications and Education

Board Certification Hematology
Internal Medicine
Pediatrics
Fellowship National Institutes of Health, Bethesda, MD
Residency Cleveland Clinic Foundation, Cleveland, OH
Internship Cleveland Clinic Foundation, Cleveland, OH
Medical School Tehran University of Medical Sciences, Tehran, Iran

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
Research

Dr. Hematti runs an active basic research lab with the goal of developing methods for ex vivo generation and expansion of hematopoietic stem cells. His clinical research interest is in using novel mobilization agents for collection of peripheral blood stem cells.


PubMed Articles
Fontana G Martin HL Lee JS Schill K Hematti P Murphy WL Mineral-Coated Microparticles Enhance mRNA-Based Transfection of Human Bone Marrow Cells. Mol Ther Nucleic Acids . 2019 Dec 6;18:455-464
[PubMed ID: 31655263]
Sabloff M Chhabra S Wang T Fretham C Kekre N Abraham A Adekola K Auletta JJ Barker C Beitinjaneh AM Bredeson C Cahn JY Diaz MA Freytes C Gale RP Ganguly S Gergis U Guinan E Hamilton BK Hashmi S Hematti P Hildebrandt G Holmberg L Hong S Lazarus HM Martino R Muffly L Nishihori T Perales MA Yared J Mineishi S Stadtmauer EA Pasquini MC Loren AW Comparison of High Doses of Total Body Irradiation in Myeloablative Conditioning before Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant . 2019 Dec;25(12):2398-2407
[PubMed ID: 31473319]
Kink JA Forsberg MH Reshetylo S Besharat S Childs CJ Pederson JD Gendron-Fitzpatrick A Graham M Bates PD Schmuck EG Raval A Hematti P Capitini CM Macrophages Educated with Exosomes from Primed Mesenchymal Stem Cells Treat Acute Radiation Syndrome by Promoting Hematopoietic Recovery. Biol Blood Marrow Transplant . 2019 Nov;25(11):2124-2133
[PubMed ID: 31394269]
Solomon SR St Martin A Shah NN Fatobene G Al Malki MM Ballen KK Bashey A Bejanyan N Bolaños Meade J Brunstein CG DeFilipp Z Champlin RE Fuchs EJ Hamadani M Hematti P Kanakry CG McGuirk JP McNiece IK Ciurea SO Pasquini MC Rocha V Romee R Patel SS Vasu S Waller EK Wingard JR Zhang MJ Eapen M Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy. Blood Adv . 2019 Oct 8;3(19):2836-2844
[PubMed ID: 31582392]
Lung DK Warrick JW Hematti P Callander NS Mark CJ Miyamoto S Alarid ET Bone Marrow Stromal Cells Transcriptionally Repress ESR1 but Cannot Overcome Constitutive ESR1 Mutant Activity. Endocrinology . 2019 Oct 1;160(10):2427-2440
[PubMed ID: 31504407]
Dhakal B Pagenkopf A Mushtaq MU Cunningham AM Flietner E Morrow Z Papadas A Hope C Leith C Hematti P Hari P Callander NS Asimakopoulos F Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma. Leuk Lymphoma . 2019 Oct;60(10):2558-2562
[PubMed ID: 30845856]
Kaufman DB Hematti P Golden RN Immunosuppression-Free Kidney Transplantation: Advancing New Treatments by Building on Our Past Foundations. WMJ . 2019 Oct;118(3):146-147
[PubMed ID: 31682753]
Zinter MS Logan BR Fretham C Sapru A Abraham A Aljurf MD Arnold SD Artz A Auletta JJ Chhabra S Copelan E Duncan C Gale RP Guinan E Hematti P Keating AK Marks DI Olsson R Savani BN Ustun C Williams KM Pasquini MC Dvorak CC Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries. Biol Blood Marrow Transplant . 2019 Sep 26;
[PubMed ID: 31563573]
Hamilton BK Liu Y Hemmer MT Majhail N Ringden O Kim D Costa L Stuart R Alousi A Pidala JA Couriel DR Aljurf M Antin JH Bredeson C Cahn JY Cairo M Choi SW Dandoy C Gale RP Gergis U Hematti P Inamoto Y Kamble RT MacMillan M Marks DI Nemecek E Nishihori T Saad A Savani BN Schriber J Seo S Socié G Teshima T Verdonck LF Waller EK Wirk M Spellman SR Arora M Chhabra S Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant . 2019 Sep;25(9):1744-1755
[PubMed ID: 31158502]
Saad A Lamb L Wang T Hemmer MT Spellman S Couriel D Alousi A Pidala J Abdel-Azim H Agrawal V Aljurf M Beitinjaneh AM Bhatt VR Buchbinder D Byrne M Cahn JY Cairo M Castillo P Chhabra S Diaz MA Farhan S Floisand Y Frangoul HA Gadalla SM Gajewski J Gale RP Gandhi M Gergis U Hamilton BK Hematti P Hildebrandt GC Kamble RT Kanate AS Khandelwal P Lazaryan A MacMillan M Marks DI Martino R Mehta PA Nishihori T Olsson RF Patel SS Qayed M Rangarajan HG Reshef R Ringden O Savani BN Schouten HC Schultz KR Seo S Shaffer BC Solh M Teshima T Urbano-Ispizua A Verdonck LF Vij R Waller EK William B Wirk B Yared JA Yu LC Arora M Hashmi S Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation. Biol Blood Marrow Transplant . 2019 Sep;25(9):1875-1883
[PubMed ID: 31085303]
Chinnadurai R Rajakumar A Schneider AJ Bushman WA Hematti P Galipeau J Potency Analysis of Mesenchymal Stromal Cells Using a Phospho-STAT Matrix Loop Analytical Approach. Stem Cells . 2019 Aug;37(8):1119-1125
[PubMed ID: 31108008]
Prokopishyn NL Logan BR Kiefer DM Sees JA Chitphakdithai P Ahmed IA Anderlini PN Beitinjaneh AM Bredeson C Cerny J Chhabra S Daly A Diaz MA Farhadfar N Frangoul HA Ganguly S Gastineau DA Gergis U Hale GA Hematti P Kamble RT Kasow KA Lazarus HM Liesveld JL Murthy HS Norkin M Olsson RF Papari M Savani BN Szer J Waller EK Wirk B Yared JA Pulsipher MA Shah NN Switzer GE O'Donnell PV Confer DL Shaw BE The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time. Biol Blood Marrow Transplant . 2019 Jul;25(7):1325-1330
[PubMed ID: 30716454]
Mehta RS Holtan SG Wang T Hemmer MT Spellman SR Arora M Couriel DR Alousi AM Pidala J Abdel-Azim H Ahmed I Aljurf M Askar M Auletta JJ Bhatt V Bredeson C Chhabra S Gadalla S Gajewski J Gale RP Gergis U Hematti P Hildebrandt GC Inamoto Y Kitko C Khandelwal P MacMillan ML Majhail N Marks DI Mehta P Nishihori T Olsson RF Pawarode A Diaz MA Prestidge T Qayed M Rangarajan H Ringden O Saad A Savani BN Seo S Shah A Shah N Schultz KR Solh M Spitzer T Szer J Teshima T Verdonck LF Williams KM Wirk B Wagner J Yared JA Weisdorf DJ GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia. Blood Adv . 2019 May 14;3(9):1441-1449
[PubMed ID: 31053571]
Inamoto Y Petri�ek I Burns L Chhabra S DeFilipp Z Hematti P Rovó A Schears R Shah A Agrawal V Ahmed A Ahmed I Ali A Aljurf M Alkhateeb H Beitinjaneh A Bhatt N Buchbinder D Byrne M Callander N Fahnehjelm K Farhadfar N Gale RP Ganguly S Hashmi S Hildebrandt GC Horn E Jakubowski A Kamble RT Law J Lee C Nathan S Penack O Pingali R Prasad P Pulanic D Rotz S Shreenivas A Steinberg A Tabbara K Tichelli A Wirk B Yared J Basak GW Battiwalla M Duarte R Savani BN Flowers MED Shaw BE Valdés-Sanz N Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant . 2019 May;25(5):e145-e154
[PubMed ID: 30521975]
Inamoto Y Petri�ek I Burns L Chhabra S DeFilipp Z Hematti P Rovó A Schears R Shah A Agrawal V Al-Khinji A Ahmed I Ali A Aljurf M Alkhateeb H Beitinjaneh A Bhatt N Buchbinder D Byrne M Callander N Fahnehjelm K Farhadfar N Gale RP Ganguly S Hildebrandt GC Horn E Jakubowski A Kamble RT Law J Lee C Nathan S Penack O Pingali R Prasad P Pulanic D Rotz S Shreenivas A Steinberg A Tabbara K Tichelli A Wirk B Yared J Basak GW Battiwalla M Duarte R Savani BN Flowers MED Shaw BE Valdés-Sanz N Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone Marrow Transplant . 2019 May;54(5):782-783
[PubMed ID: 30809032]
Inamoto Y Petri�ek I Burns L Chhabra S DeFilipp Z Hematti P Rovó A Schears R Shah A Agrawal V Al-Khinji A Ahmed I Ali A Aljurf M Alkhateeb H Beitinjaneh A Bhatt N Buchbinder D Byrne M Callander N Fahnehjelm K Farhadfar N Gale RP Ganguly S Hildebrandt GC Horn E Jakubowski A Kamble RT Law J Lee C Nathan S Penack O Pingali R Prasad P Pulanic D Rotz S Shreenivas A Steinberg A Tabbara K Tichelli A Wirk B Yared J Basak GW Battiwalla M Duarte R Savani BN Flowers MED Shaw BE Valdés-Sanz N Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone Marrow Transplant . 2019 May;54(5):648-661
[PubMed ID: 30531955]
Parikh SH Satwani P Ahn KW Sahr NA Fretham C Abraham AA Agrawal V Auletta JJ Abdel-Azim H Copelan E Diaz MA Dvorak CC Frangoul HA Freytes CO Gadalla SM Gale RP George B Gergis U Hashmi S Hematti P Hildebrandt GC Keating AK Lazarus HM Myers KC Olsson RF Prestidge T Rotz SJ Savani BN Shereck EB Williams KM Wirk B Pasquini MC Loren AW Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant. JAMA Pediatr . 2019 May 1;173(5):e190081
[PubMed ID: 30882883]
Chamberlain CS Clements AEB Kink JA Choi U Baer GS Halanski MA Hematti P Vanderby R Extracellular Vesicle-Educated Macrophages Promote Early Achilles Tendon Healing. Stem Cells . 2019 May;37(5):652-662
[PubMed ID: 30720911]
Brunstein CG Pasquini MC Kim S Fei M Adekola K Ahmed I Aljurf M Agrawal V Auletta JJ Battiwalla M Bejanyan N Bubalo J Cerny J Chee L Ciurea SO Freytes C Gadalla SM Gale RP Ganguly S Hashmi SK Hematti P Hildebrandt G Holmberg LA Lahoud OB Landau H Lazarus HM de Lima M Mathews V Maziarz R Nishihori T Norkin M Olsson R Reshef R Rotz S Savani B Schouten HC Seo S Wirk BM Yared J Mineishi S Rogosheske J Perales MA Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant . 2019 Mar;25(3):480-487
[PubMed ID: 30423481]
Sahasrabudhe K Otto M Hematti P Kenkre V TCR αβ+/CD19+ cell depletion in haploidentical hematopoietic allogeneic stem cell transplantation: a review of current data. Leuk Lymphoma . 2019 Mar;60(3):598-609
[PubMed ID: 30187806]